BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Prognosis
5 results:

  • 1. ext2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma.
    Selvan AJA; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):282-289. PubMed ID: 38155009
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
    Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
    J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer.
    Abraham E; Roshan D; Tran B; Wykes J; Campbell P; Ebrahimi A
    J Surg Oncol; 2019 Nov; 120(6):1016-1022. PubMed ID: 31452204
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic significance of radiologically determined neck node volume in head and neck cancer: a systematic review.
    Lodder WL; Pameijer FA; Rasch CR; van den Brekel MW; Balm AJ
    Oral Oncol; 2012 Apr; 48(4):298-302. PubMed ID: 22112442
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic assessment of sonography and tumor volumetry in advanced cancer of the head and neck by use of doppler ultrasonography.
    Dietz A; Delorme S; Rudat V; Zuna I; Conradt C; Vanselow B; Weidauer H
    Otolaryngol Head Neck Surg; 2000 Apr; 122(4):596-601. PubMed ID: 10740188
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.